Our internationally-renowned team advises on all types of IP issues in the field of Pharmaceuticals.
Our Pharmaceuticals group enjoys an international reputation, and we are proud to have represented a wide range of companies on contentious and non-contentious matters touching on every stage of the product life-cycle.
Several members of the group have previously held in-house positions within the pharmaceutical industry and we actively leverage this experience across the group. Many of the group are active members of the Pharmaceutical Trade Marks Group (PTMG), and also the Bio Industry Association (BIA) where we have a seat on its Intellectual Property Advisory Committee.
We work regularly alongside in-house legal counsel, and are equally comfortable directly liaising with colleagues in R&D, Business Development, Regulatory and Commercial affairs.
Our attorneys and solicitors have significant experience in advising on all types of IP issues relevant to the pharmaceuticals sector, including patent prosecution, trade mark issues, including the interface with regulatory matters, design protection and enforcement, and contentious work, including oppositions and litigation. We also have expertise in obtaining patent term extensions and providing commercial advice on infringement and validity, licensing opportunities, and parallel imports.
We are active across the Life Sciences field and work with a wide range of technologies from new APIs and manufacturing processes, to formulations, medical uses and diagnostic processes, biotechnological inventions, as well as cosmetics and nutraceuticals.
Some of the technologies we have recently advised on include:
We represent clients from around the world, including Australia, Canada, China, Germany, India, Israel, Japan, New Zealand, Portugal, South Korea, the UK and the US.
Swiss Biotech Day 2018, Basel, Switzerland Patent Attorneys Dr Craig Turner and Julie Barrett- Major represented the firm at the Swiss Biotech Day 2018, in Basel, Switzerland, on 3 May 2018. According to European Biotechnology Magazine, “with more than 600 senior executives from the Swiss life science industry and from across Europe the annually held was as popular as… Read more »
CRISPR: the gene editing tool and related patents CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology is considered as one of the biggest innovations of the century in the biotechnology field and has gained a lot of attention worldwide, especially in the US and Europe in the area of Intellectual Property Rights. Research has… Read more »